Ermium Therapeutics
VerifiedDeveloping innovative therapies for auto-immune diseases, based on a breakthrough discovery.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$26—40m (Dealroom.co estimates Jun 2022.)
Company register number 851998039
Paris Île-de-France (HQ)